Australian Society for Antimicrobials
PO Box 8266 Angelo St, South Perth, Western Australia 6151
Fax: 61 8 9450 8553, Email:, Twitter: @AusAntibiotics

ASA Research Grants

Annual grants of up to $25,000 to support original research have been made available by the Australian Society of Antimicrobials (ASA). Grants may/may not be awarded annually at the discretion of the ASA Executive Committee. The following conditions apply:

  • Funding is limited to ASA financial members.
  • The Principal Investigator (PI) must have been an ASA member for at least twelve months
  • The successful applicant will present their work at an ASA annual scientific meeting
  • If applicable the PI will submit an article for the ASA newsletter and website
  • ASA will be acknowledged on all resulting publications and presentations
  • 12 and 24 month progress reports must be submitted to the ASA committee

The research funds are to be used for the project, as per the budget application only. ASA does not support an institution's  infrastructure or overhead costs.


The application must be performed on line via the ASA website Research Grant Application Form and must include:


  • A copy of the PI's CV.
  • Head of Department confirmation of the application and the Department has the resources required to undertake the project.

The grant application and CV will be assessed by a panel of at least six independent reviewers using a standardised scoring system. Applicants will be informed of the decision one week before the ASA annual scientific meeting "Antimicrobials 2016".

Applications will be accepted online from 23rd August to 30 October 2015.


Click here for the Research Grant Application Form.


For further enquiries please contact the ASA secretary on


Previous ASA Research Grants


Identification of the Pharmacokinetics Pharmacodynamics (PK/PD) Index and Targets of Fosfomycin for Bacterial Killing and Prevention of Resistance against Multidrug-resistant Pseudomonas aeruginsoa   

Phillip Bergen, Monash University


Promiscuous Plasmids in Avian Pathogenic (APEC) and Faecal Escherichia coli (AFEC): How to Safeguard Australia

Justine Gibson, Queensland University



Randomised Controlled Trial of Meropenem versus Piperacillin-Tazobactam for Definitive Treatment of

Bloodstream Infections Due to Ceftriaxone Non-Susceptible Escherichia coli and Klebsiella spp .

David Paterson, Queensland University


Complete Sequencing of Selected, Informative Multi-resistance Plasmids from Enterobacteriaceae

Clinical Isolates.

Sally Partridge, Westmead Hospital


VANESSA (VANcomycin Efficacy in Staphylococcal Sepsis in Australasia): A Prospective, Multi-centre, Observational Cohort Study of Outcomes in Staphylococcus aureus Bacteraemia

Natasha Holmes, Austin Health